|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
| We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/11/21 Audioeye Inc. 10-Q 6/30/21 50:4.6M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 733K
2: EX-10.1 Material Contract HTML 24K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
11: R1 Document and Entity Information HTML 71K
12: R2 Balance Sheets HTML 102K
13: R3 Balance Sheets (Parenthetical) HTML 41K
14: R4 Statements of Operations HTML 75K
15: R5 Statements of Stockholders' Equity HTML 80K
16: R6 Statements of Cash Flows HTML 92K
17: R7 Basis of Presentation HTML 20K
18: R8 Summary of Significant Accounting Policies HTML 118K
19: R9 Capital Raise and Liquidity HTML 18K
20: R10 Lease Liabilities and Right of Use Assets HTML 71K
21: R11 Debt HTML 19K
22: R12 Series A Convertible Preferred Stock HTML 21K
23: R13 Related Party Transactions HTML 20K
24: R14 Commitments and Contingencies HTML 20K
25: R15 Summary of Significant Accounting Policies HTML 131K
(Policies)
26: R16 Summary of Significant Accounting Policies HTML 111K
(Tables)
27: R17 Lease Liabilities and Right of Use Assets (Tables) HTML 73K
28: R18 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 25K
Disaggregate revenue (Details)
29: R19 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 24K
Deferred Revenue, by Arrangement (Details)
30: R20 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 23K
Deferred commission cost (Details)
31: R21 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Stock HTML 24K
compensation expense (Details)
32: R22 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 25K
Antidilutive Securities Excluded from Computation
of Earnings Per Share (Details)
33: R23 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 59K
Summary of Stock Option, Warrants, and RSUs
Activity (Details)
34: R24 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - HTML 93K
Additional Information (Details)
35: R25 Capital Raise and Liquidity (Details) HTML 31K
36: R26 LEASE LIABILITIES AND RIGHT OF USE ASSETS - Right HTML 21K
to use assets under finance leases (Details)
37: R27 LEASE LIABILITIES AND RIGHT OF USE ASSETS - Future HTML 35K
minimum finance lease payments (Details)
38: R28 LEASE LIABILITIES AND RIGHT OF USE ASSETS - Future HTML 35K
minimum operating lease payments (Details)
39: R29 LEASE LIABILITIES AND RIGHT OF USE ASSETS - HTML 33K
Finance Leases and Operating Leases (Details)
40: R30 LEASE LIABILITIES AND RIGHT OF USE ASSETS - Lease HTML 29K
expenses (Details)
41: R31 LEASE LIABILITIES AND RIGHT OF USE ASSETS - HTML 25K
Remaining lease terms and discount rates (Details)
42: R32 LEASE LIABILITIES AND RIGHT OF USE ASSETS - HTML 23K
Additional Information (Details)
43: R33 Debt (Details) HTML 28K
44: R34 SERIES A CONVERTIBLE PREFERRED STOCK - Additional HTML 21K
Information (Details)
45: R35 Related Party Transactions (Details) HTML 18K
46: R36 COMMITMENTS AND CONTINGENCIES - Additional HTML 17K
Information (Details)
48: XML IDEA XML File -- Filing Summary XML 86K
10: XML XBRL Instance -- aeye-20210630x10q_htm XML 918K
47: EXCEL IDEA Workbook of Financial Reports XLSX 53K
6: EX-101.CAL XBRL Calculations -- aeye-20210630_cal XML 140K
7: EX-101.DEF XBRL Definitions -- aeye-20210630_def XML 261K
8: EX-101.LAB XBRL Labels -- aeye-20210630_lab XML 663K
9: EX-101.PRE XBRL Presentations -- aeye-20210630_pre XML 521K
5: EX-101.SCH XBRL Schema -- aeye-20210630 XSD 98K
49: JSON XBRL Instance as JSON Data -- MetaLinks 222± 325K
50: ZIP XBRL Zipped Folder -- 0001104659-21-103588-xbrl Zip 157K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 10-Q
(Mark One)
i ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended i June 30, 2021
or
i ☐ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from [ ] to [ ]
Commission File Number: i 001-38640
AudioEye, Inc.
(Exact name of registrant as specified in its charter)
i Delaware |
| i 20-2939845 |
(State
or other jurisdiction of incorporation or |
| (I.R.S. Employer Identification No.) |
|
|
|
i 5210 East Williams Circle, i Suite 750, |
| i 85711 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: i 866- i 331-5324
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
i Common Stock, par value $0.00001 per share | i AEYE | The i Nasdaq Capital Market |
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the last 90 days. i Yes ⌧ No ◻
Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). i Yes ⌧ No ◻
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ◻ | Accelerated filer | ◻ |
i Non-accelerated filer | ⌧ | Smaller reporting company | i ⌧ |
Emerging growth company | i ◻ |
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ◻ No i ⌧
As of August 6, 2021, i 11,336,551 shares of the registrant’s common stock were issued and outstanding.
| | |
| | Page |
1 | ||
| | |
1 | ||
| | |
| Balance Sheets as of June 30, 2021 and December 31, 2020 (unaudited) | 2 |
| | |
| Statements of Operations for the three and six months ended June 30, 2021 and 2020 (unaudited) | 3 |
| | |
| 4 | |
| | |
| Statements of Cash Flows for the six months ended June 30, 2021 and 2020 (unaudited) | 5 |
| | |
| 6 | |
| | |
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15 | |
| | |
24 | ||
| | |
24 | ||
| | |
26 | ||
| | |
26 | ||
| | |
26 | ||
| | |
26 | ||
| | |
27 | ||
| | |
| 29 |
PART I — FINANCIAL INFORMATION
Item 1. Financial Statements
The financial information set forth below with respect to the financial statements as of June 30, 2021 and December 31, 2020 and for the three-and six-month periods ended June 30, 2021 and 2020 is unaudited. This financial information, in the opinion of our management, includes all adjustments consisting of normal recurring entries necessary for the fair presentation of such data. The results of operations for the three- and six-month periods ended June 30, 2021 are not necessarily indicative of results to be expected for any subsequent period. Our fiscal year end is December 31. Certain prior period amounts have been reclassified to conform to current period classification. The Company presents its unaudited financial statements, notes, and other financial information rounded to the nearest thousand United States Dollars (“U.S. Dollar”), except for per share data.
1
AUDIOEYE, INC.
BALANCE SHEETS
(unaudited)
| | | | | | |
|
| June 30, |
| December 31, | ||
(in thousands, except per share data) | | 2021 | | 2020 | ||
ASSETS |
|
| ||||
Current assets: |
| |
|
| |
|
Cash | | $ | i 24,751 | | $ | i 9,095 |
Accounts receivable, net of allowance for doubtful accounts of $ i 146 and $ i 79, respectively | |
| i 3,762 | |
| i 5,096 |
Deferred costs, short term | |
| i 142 | |
| i 152 |
Prepaid expenses and other current assets | |
| i 453 | |
| i 288 |
Total current assets | |
| i 29,108 | |
| i 14,631 |
| | | | | | |
Property and equipment, net of accumulated depreciation of $ i 244 and $ i 209, respectively | |
| i 153 | |
| i 91 |
Right of use assets | |
| i 508 | |
| i 617 |
Deferred costs, long term | |
| i 66 | |
| i 77 |
Intangible assets, net of accumulated amortization of $ i 4,876 and $ i 4,328, respectively | |
| i 2,483 | |
| i 2,137 |
Goodwill | |
| i 701 | |
| i 701 |
Total assets | | $ | i 33,019 | | $ | i 18,254 |
| | | | | | |
LIABILITIES AND STOCKHOLDERS' EQUITY | |
| | |
|
|
Current liabilities: | |
| | |
|
|
Accounts payable and accrued expenses | | $ | i 3,175 | | $ | i 2,190 |
Finance lease liabilities | |
| i 69 | | | i 49 |
Operating lease liabilities | |
| i 240 | |
| i 229 |
Deferred revenue | |
| i 5,972 | |
| i 6,328 |
Term loan, short term | | | i — | | | i 219 |
Total current liabilities | |
| i 9,456 | |
| i 9,015 |
| | | | | | |
Long term liabilities: | |
| | |
|
|
Finance lease liabilities | |
| i 71 | |
| i 12 |
Operating lease liabilities | |
| i 304 | |
| i 427 |
Deferred revenue | |
| i 34 | |
| i 83 |
Term loan, long term | |
| i — | |
| i 1,083 |
Total liabilities | |
| i 9,865 | |
| i 10,620 |
| | | | | | |
Stockholders' equity: | |
| | |
|
|
Preferred stock, $ i i 0.00001 / par value, i i 10,000 / shares authorized | |
| | |
|
|
Series A Convertible Preferred Stock, $ i i 0.00001 / par value, i i 200 / shares designated, i zero and i 90 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively | |
| i — | |
| i 1 |
Common stock, $ i i 0.00001 / par value, i i 50,000 / shares authorized, i 11,277 and i 10,130 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively | |
| i 1 | |
| i 1 |
Additional paid-in capital | |
| i 84,786 | |
| i 64,716 |
Accumulated deficit | |
| ( i 61,633) | |
| ( i 57,084) |
Total stockholders' equity | |
| i 23,154 | |
| i 7,634 |
| | | | | | |
Total liabilities and stockholders' equity | | $ | i 33,019 | | $ | i 18,254 |
See Notes to Unaudited Financial Statements
2
AUDIOEYE, INC.
STATEMENTS OF OPERATIONS
(unaudited)
| | | | | | | | | | | | |
| | Three months ended June 30, | | Six months ended June 30, | ||||||||
(in thousands, except per share data) |
| 2021 |
| 2020 |
| 2021 |
| 2020 | ||||
Revenue |
| $ | i 6,021 |
| $ | i 5,283 |
| $ | i 11,809 | | $ | i 9,544 |
| |
| | |
| | |
| | |
| |
Cost of revenue | |
| i 1,512 | |
| i 1,607 | |
| i 2,865 | |
| i 2,927 |
| |
| | |
| | |
| | |
| |
Gross profit | |
| i 4,509 | |
| i 3,676 | |
| i 8,944 | |
| i 6,617 |
| |
| | |
| | |
| | |
| |
Operating expenses: | |
| | |
| | |
| | |
| |
Selling and marketing | |
| i 3,380 | |
| i 1,705 | |
| i 6,134 | |
| i 3,523 |
Research and development | |
| i 1,307 | |
| i 265 | |
| i 2,339 | |
| i 598 |
General and administrative | |
| i 2,917 | |
| i 2,556 | |
| i 6,327 | |
| i 4,988 |
Total operating expenses | |
| i 7,604 | |
| i 4,526 | |
| i 14,800 | |
| i 9,109 |
| |
| | |
| | |
| | |
| |
Operating loss | |
| ( i 3,095) | |
| ( i 850) | |
| ( i 5,856) | |
| ( i 2,492) |
| |
| | |
| | |
| | |
| |
Other income (expense): | |
| | |
| | |
| | |
| |
Change in fair value of warrant liability | |
| i — | |
| ( i 501) | |
| — | |
| ( i 473) |
Gain on loan forgiveness | | | i 1,316 | | | i — | | | i 1,316 | | | — |
Interest expense | |
| ( i 5) | |
| ( i 56) | |
| ( i 9) | |
| ( i 106) |
Total other income (expense) | |
| i 1,311 | |
| ( i 557) | |
| i 1,307 | |
| ( i 579) |
| |
| | |
| | |
| | |
| |
Net loss | |
| ( i 1,784) | |
| ( i 1,407) | |
| ( i 4,549) | |
| ( i 3,071) |
| |
| | |
| | |
| | |
| |
Dividends on Series A Convertible Preferred Stock | |
| ( i 58) | |
| ( i 12) | |
| ( i 69) | |
| ( i 26) |
| |
| | |
| | |
| | |
| |
Net loss available to common stockholders | | $ | ( i 1,842) | | $ | ( i 1,419) | | $ | ( i 4,618) | | $ | ( i 3,097) |
| |
| | |
| | |
| | |
| |
Net loss per common share-basic and diluted | | $ | ( i 0.17) | | $ | ( i 0.16) | | $ | ( i 0.43) | | $ | ( i 0.35) |
| |
| | |
| | |
| | |
| |
Weighted average common shares outstanding-basic and diluted | |
| i 10,992 | |
| i 8,937 | |
| i 10,726 | |
| i 8,907 |
See Notes to Unaudited Financial Statements
3
AUDIOEYE, INC.
STATEMENTS OF STOCKHOLDERS’ EQUITY
THREE AND SIX MONTHS ENDED JUNE 30, 2021 AND 2020
(unaudited)
| | | | | | | | | | | | | | | | | | | |
|
|
|
|
| |
|
|
|
| |
| Additional |
| | |
| | | |
| | Common stock | | Preferred stock | | Paid-in | | Accumulated | | | | ||||||||
(in thousands) | | Shares | | Amount | | Shares | | Amount | | Capital | | Deficit | | Total | |||||
Balance, December 31, 2020 | | i 10,130 | | $ | i 1 | | i 90 | | $ | i 1 | | $ | i 64,716 | | $ | ( i 57,084) | | $ | i 7,634 |
Issuance of common stock for cash, net of transaction expenses | | i 472 | | | — | | — | | | — | | | i 16,534 | | | — | | | i 16,534 |
Common stock issued upon exercise of warrants and options on a cash basis |
| i 22 | | | — | | — | | | — | | | i 148 | | | — | | | i 148 |
Common stock issued upon exercise of warrants and options on a cashless basis |
| i 121 | | | — | | — | | | — | | | — | | | — | | | — |
Common stock issued upon settlement of restricted stock units | | i 92 | | | — | | — | | | — | | | — | | | — | | | — |
Issuance of common stock for services | | i 2 | | | — | | — | | | — | | | — | | | — | | | — |
Surrender of stock to cover tax liability on settlement of employee stock-based awards | | ( i 16) | | | — | | — | | | — | | | ( i 373) | | | — | | | ( i 373) |
Stock-based compensation |
| — | | | — | | — | | | — | | | i 1,781 | | | — | | | i 1,781 |
Net loss |
| — | | | — | | — | | | — | | | — | | | ( i 2,765) | | | ( i 2,765) |
Balance, March 31, 2021 |
| i 10,823 | | $ | i 1 | | i 90 | | $ | i 1 | | $ | i 82,806 | | $ | ( i 59,849) | | $ | i 22,959 |
Common stock issued upon conversion of preferred stock | | i 279 | | | — | | ( i 90) | | | ( i 1) | | | i 1 | | | — | | | — |
Common stock issued upon exercise of warrants and options on a cash basis | | i 53 | | | — | | — | | | — | | | i 255 | | | — | | | i 255 |
Common stock issued upon exercise of warrants and options on a cashless basis | | i 33 | | | — | | — | | | — | | | — | | | — | | | — |
Common stock issued upon settlement of restricted stock units | | i 78 | | | — | | — | | | — | | | — | | | — | | | — |
Issuance of common stock for services | | i 13 | | | — | | — | | | — | | | — | | | — | | | — |
Surrender of stock to cover tax liability on settlement of employee stock-based awards | | ( i 2) | | | — | | — | | | — | | | ( i 39) | | | — | | | ( i 39) |
Stock-based compensation | | — | | | — | | — | | | — | | | i 1,763 | | | — | | | i 1,763 |
Net loss |
| — | | | — | | — | | | — | | | — | | | ( i 1,784) | | | ( i 1,784) |
Balance, June 30, 2021 |
| i 11,277 | | $ | i 1 | | — | | $ | — | | $ | i 84,786 | | $ | ( i 61,633) | | $ | i 23,154 |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | Additional | | | | | | | |
| | Common stock | | Preferred stock | | Paid-in | | Accumulated | | | | ||||||||
(in thousands) |
| Shares |
| Amount |
| Shares |
| Amount |
| Capital |
| Deficit |
| Total | |||||
Balance, December 31, 2019 | | i 8,877 | | $ | i 1 | | i 105 | | $ | i 1 | | $ | i 51,490 | | $ | ( i 49,926) | | $ | i 1,566 |
Stock-based compensation | | — | | | — | | — | | | — | | | i 256 | | | — | | | i 256 |
Net loss | | — | | | — | | — | | | — | | | — | | | ( i 1,664) | | | ( i 1,664) |
Balance, March 31, 2020 | | i 8,877 | | $ | i 1 | | i 105 | | $ | i 1 | | $ | i 51,746 | | $ | ( i 51,590) | | $ | i 158 |
Common stock issued upon conversion of preferred stock |
| i 14 | |
| — |
| ( i 5) | |
| — | |
| — | |
| — | |
| — |
Common stock issued in exchange for exercise of warrants and options on a cashless basis |
| i 177 | |
| — |
| — | |
| — | |
| — | |
| — | |
| — |
Common stock issued in exchange for options exercised on a cash basis | | i 45 | | | — | | — | | | — | | | i 44 | | | — | | | i 44 |
Stock-based compensation |
| — | |
| — |
| — | |
| — | |
| i 659 | |
| — | |
| i 659 |
Net loss |
| — | |
| — |
| — | |
| — | |
| — | |
| ( i 1,407) | |
| ( i 1,407) |
Balance, June 30, 2020 |
| i 9,113 | | $ | i 1 |
| i 100 | | $ | i 1 | | $ | i 52,449 | | $ | ( i 52,997) | | $ | ( i 546) |
See Notes to Unaudited Financial Statements
4
AUDIOEYE, INC.
STATEMENTS OF CASH FLOWS
(unaudited)
| | | | | | |
| | Six months ended June 30, | ||||
(in thousands) |
| 2021 |
| 2020 | ||
CASH FLOWS FROM OPERATING ACTIVITIES: |
| |
|
| |
|
Net loss | | $ | ( i 4,549) | | $ | ( i 3,071) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |
| | |
| |
Depreciation and amortization | |
| i 600 | |
| i 411 |
Loss on impairment of long-lived assets | | | i 10 | | | i — |
Loss on disposal of property and equipment | | | i 12 | | | i — |
Stock-based compensation expense | | | i 3,544 | | | i 915 |
Amortization of deferred commissions | | | i 99 | | | i 111 |
Amortization of debt issuance costs | |
| i — | |
| i 110 |
Amortization of right of use assets | |
| i 109 | |
| i 103 |
Change in fair value of warrant liability | |
| i — | |
| i 473 |
Gain on loan forgiveness | | | ( i 1,316) | | | i — |
Provision for accounts receivable | |
| i 76 | |
| i 30 |
Changes in operating assets and liabilities: | |
| | |
| |
Accounts receivable and unbilled receivables | |
| i 1,258 | |
| ( i 936) |
Prepaid expenses and other assets | |
| ( i 243) | |
| ( i 92) |
Accounts payable and accruals | | | i 984 | | | i 1,536 |
Operating lease liability | | | ( i 112) | | | ( i 102) |
Deferred revenue | | | ( i 405) | | | ( i 279) |
Net cash provided by (used in) operating activities | |
| i 67 | |
| ( i 791) |
| | | | | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | |
| |
Software development costs | |
| ( i 843) | |
| ( i 370) |
Patent costs | | | ( i 50) | | | i — |
Net cash used in investing activities | |
| ( i 893) | |
| ( i 370) |
| | | | | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | |
| |
Proceeds from common stock offering, net of transaction costs | | | i 16,534 | | | i — |
Proceeds from term loan | | | i — | | | i 1,302 |
Proceeds from exercise of options and warrants | |
| i 403 | |
| i 44 |
Payments related to settlement of employee shared-based awards | | | ( i 412) | | | i — |
Repayments of finance leases | |
| ( i 43) | |
| ( i 27) |
Net cash provided by financing activities | |
| i 16,482 | |
| i 1,319 |
| | | | | | |
Net increase in cash | |
| i 15,656 | |
| i 158 |
Cash-beginning of period | |
| i 9,095 | |
| i 1,972 |
Cash-end of period | | $ | i 24,751 | | $ | i 2,130 |
See Notes to Unaudited Financial Statements
5
NOTE 1 — BASIS OF PRESENTATION
The accompanying unaudited interim financial statements of AudioEye, Inc. (“we”, “our” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) and the rules of the Securities and Exchange Commission (the “SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 (the “2020 Form 10-K”), as filed with the SEC on March 11, 2021.
In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Certain information and disclosures normally contained in the audited financial statements as reported in the Company’s Annual Report on Form 10-K have been condensed or omitted in accordance with the SEC’s rules and regulations for interim reporting. Certain prior period amounts have been reclassified to conform to current period classification. Reclassifications had no material effect on prior year net loss, earnings per share, or shareholders’ equity.
iNOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Our significant accounting policies are presented in “Note 3 – Significant Accounting Policies” in the 2020 Form 10-K. Users of financial information for interim periods are encouraged to refer to the footnotes to the financial statements contained in the 2020 Form 10-K when reviewing interim financial results.
iUse of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the financial statements and during the reporting period. On an ongoing basis, management evaluates its estimates and judgments, including those related to stock-based compensation, capitalization of software development costs, allowance for doubtful accounts, and impairment of long-lived assets and goodwill. Actual results may differ from these estimates.
iRevenue Recognition
We derive our revenue primarily from the sale of internally-developed software by a software-as-a-service (“SaaS”) delivery model, as well as ongoing from professional services support, through our direct sales force or through third-party resellers. Our SaaS fees include continuous support and maintenance.
We recognize revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of ASC 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
We determine revenue recognition through the following five steps:
| ● | Identify the contract with the customer; |
| ● | Identify the performance obligations in the contract; |
/6
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
| ● | Determine the transaction price; |
| ● | Allocate the transaction price to the performance obligations in the contract; and |
| ● | Recognize revenue when, or as, the performance obligations are satisfied. |
Performance obligations are the unit of accounting for revenue recognition and generally represent the distinct goods or services that are promised to the customer. If we determine that we have not satisfied a performance obligation, we will defer recognition of the revenue until the performance obligation is deemed to be satisfied. SaaS agreements are generally non-cancelable, although clients typically have the right to terminate their contracts for cause if we fail to perform material obligations.
Our SaaS (also referred to as “subscription”) revenue is comprised of fixed subscription fees from customer accounts on our platform. SaaS revenue is recognized on a ratable basis over the contractual subscription term of the arrangement beginning on the date that our service is made available to the customer. Certain SaaS fees are invoiced in advance on an annual, semi-annual, or quarterly basis. Any funds received for services not provided yet are held in deferred revenue and are recorded as revenue when the related performance obligations have been satisfied.
Non-subscription revenue consists of PDF remediation, Mobile App report and is recognized upon delivery. Consideration payable under these arrangements is based on usage.
iThe following table presents our revenues disaggregated by sales channel:
| | | | | | |
| | Six months ended | ||||
| | June 30, | ||||
(in thousands) |
| 2021 |
| 2020 | ||
Partner and Marketplace | | $ | i 6,552 | | $ | i 4,232 |
Enterprise | |
| i 5,257 | |
| i 5,312 |
Total revenues | | $ | i 11,809 | | $ | i 9,544 |
The Company records accounts receivable for amounts invoiced to customers for which the Company has an unconditional right to consideration as provided under the contractual arrangement. Unbilled receivables include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. Deferred revenue includes payments received in advance of performance under the contract. Our unbilled receivables and deferred revenue are reported on an individual contract basis at the end of each reporting period. Unbilled receivables are classified as current or noncurrent based on the timing of when we expect to bill the customer. Deferred revenue is classified as current or noncurrent based on the timing of when we expect to recognize revenue.
iThe table below summarizes our deferred revenue as of June 30, 2021 and December 31, 2020:
| | | | | | |
|
| June 30, |
| December 31, | ||
(in thousands) | | 2021 | | 2020 | ||
Deferred revenue - current | | $ | i 5,972 | | $ | i 6,328 |
Deferred revenue - noncurrent | | | i 34 | | | i 83 |
Total deferred revenue | | $ | i 6,006 | | $ | i 6,411 |
7
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
In the six-month period ended June 30, 2021 we recognized $ i 4,537,000, or i 71%, in revenue from deferred revenue outstanding as of December 31, 2020.
In the three months ended June 30, 2021, two customers (including affiliates of such customers) accounted for i 20% and i 10%, respectively, of our total revenue. In the six months ended June 30, 2021, three customers (including affiliates of such customers) accounted for i 20%, i 10%, and i 10%, respectively, of our total revenue. In the three and six months ended June 30, 2020, one customer accounted for i 16%, and i 17%, respectively, of our total revenue.
Three customers represented i 19%, i 14% and i 11%, respectively, of total accounts receivable as of June 30, 2021. Three customers with long standing relationships with the Company represented i 25%, i 13% and i 13%, respectively, of total accounts receivable as of December 31, 2020.
iDeferred Costs (Contract acquisition costs)
We capitalize initial and renewal sales commissions in the period in which the commission is earned, which generally occurs when a customer contract is obtained, and amortize deferred commission costs on a straight-line basis over the expected period of benefit, which we have deemed to be the contract term, except when the commission payment is expected to provide economic benefit for a period longer than the contract term, such as for new customer or incremental sales where renewals are expected, and renewal commissions are not commensurate with initial commissions. As a practical expedient, we expense sales commissions as incurred when the amortization period of related deferred commission costs would have been one year or less.
iThe table below summarizes the deferred commission costs as of June 30, 2021 and December 31, 2020:
| | | | | | |
| | June 30, | | December 31, | ||
(in thousands) |
| 2021 |
| 2020 | ||
Deferred costs - current | | $ | i 142 | | $ | i 152 |
Deferred costs - noncurrent | |
| i 66 | |
| i 77 |
Total deferred costs | | $ | i 208 | | $ | i 229 |
Amortization expense associated with sales commissions was included in selling and marketing expenses on the statements of operations and totaled $ i 52,000 and $ i 99,000 for the three- and six-month periods ended June 30, 2021, respectively, and $ i 55,000 and $ i 111,000 for the three- and six-month periods ended June 30, 2020, respectively. There were i no impairment losses for these capitalized costs for the three and six months ended June 30, 2021 and 2020.
/ iStock-Based Compensation
The Company periodically issues options, warrants, restricted stock units (“RSUs”), and shares of its common stock as compensation for services received from its employees, directors, and consultants. The fair value of the award is measured on the grant date. The fair value amount is then recognized as expense over the requisite vesting period during which services are required to be provided in exchange for the award. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.
8
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
The fair value of options and warrants awards is measured on the grant date using a Black-Scholes option pricing model, which includes assumptions that are subjective and are generally derived from external data (such as risk-free rate of interest) and historical data (such as volatility factor, expected term, and forfeiture rates). Future grants of equity awards accounted for as stock-based compensation could have a material impact on reported expenses depending upon the number, value, and vesting period of future awards.
We estimate the fair value of restricted stock unit awards with time- or performance-based vesting using the value of our common stock on the date of grant. We estimate the fair value of market-based restricted stock unit awards using a Monte Carlo simulation model on the date of grant.
We expense the compensation cost associated with time-based options, warrants and RSUs as the restriction period lapses, which is typically a one- to three-year service period with the Company. Compensation expense related to performance-based options and RSUs is recognized on a straight-line basis over the requisite service period, provided that it is probable that performance conditions will be achieved, with probability assessed on a quarterly basis and any changes in expectations recognized as an adjustment to earnings in the period of the change. Compensation cost is not recognized for service- and performance-based awards that do not vest because service or performance conditions are not satisfied and any previously recognized compensation cost is reversed. Compensation costs related to awards with market conditions are recognized on a straight-line basis over the requisite service period regardless of whether the market condition is satisfied, and is not reversed provided that the requisite service period derived from the Monte-Carlo simulation has been completed. If vesting occurs prior to the end of the requisite service period, expense is accelerated and fully recognized through the vesting date.
The following table summarizes the stock-based compensation expense recorded for the three and six months ended June 30, 2021 and 2020:
i
| | | | | | | | | | | | |
| | Three months ended June 30, | | Six months ended June 30, | ||||||||
(in thousands) |
| 2021 |
| 2020 |
| 2021 |
| 2020 | ||||
Stock Options | | $ | i 226 | | $ | i 36 | | $ | i 375 | | $ | i 121 |
RSUs | |
| i 1,284 | |
| i 623 | |
| i 2,882 | |
| i 794 |
Unrestricted Shares of Common Stock | | | i 253 | | | i — | | | i 287 | | | i — |
Total | | $ | i 1,763 | | $ | i 659 | | $ | i 3,544 | | $ | i 915 |
As of June 30, 2021, the outstanding unrecognized stock-based compensation expense related to options and RSUs was $ i 1,318,000 and $ i 12,440,000, respectively, which may be recognized through March 2026, subject to achievement of service, performance, and market conditions
9
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
In the first quarter of 2021, we granted i 100,000 RSUs with performance-based and market-based conditions to our Interim Chief Executive Officer (“CEO”). The performance condition for i 50,000 of such RSUs is based on the achievement of Monthly Recurring Revenue (“MRR”) targets. In the six months ended June 30, 2021, stock-based compensation expense associated with performance-based RSUs awarded to our CEO in current and previous years was i zero and $ i 311,000, respectively. We did not record any stock-based compensation expense related to the i 50,000 performance-based RSUs awarded to our CEO in 2021 as the achievement of performance targets during the requisite period was not deemed probable. The Company will continue to reassess the probability of achieving the performance conditions in future periods and record the appropriate expense if necessary. The market condition for the remaining i 50,000 RSUs in the award is based on the Company’s stock price targets. The Company used a Monte Carlo simulation to determine the grant-date fair value for the market-based RSUs. The weighted-average assumptions used in the Monte-Carlo simulation were as follows: 5-year historical volatility of i 116.95%, 5-year risk-free rate of i 0.79%, and a performance period of i 5 years. The Company recorded $ i 1,056,000 in stock-based compensation expense associated to market-based RSUs in the six months ended June 30, 2021, $ i 277,000 of which were related to RSUs granted in the current fiscal year.
iEarnings (Loss) Per Share (“EPS”)
Basic EPS is calculated by dividing net income (loss) available to common stockholders by the weighted average number of shares of the Company’s common stock outstanding during the period. Diluted EPS is calculated based on the net income (loss) available to common stockholders and the weighted average number of shares of common stock outstanding during the period, adjusted for the effects of all potential dilutive common stock issuances related to options, warrants, restricted stock units and convertible preferred stock. The dilutive effect of our stock-based awards and warrants is computed using the treasury stock method, which assumes all stock-based awards and warrants are exercised and the hypothetical proceeds from exercise are used to purchase common stock at the average market price during the period. The incremental shares (i.e., the difference between shares assumed to be issued versus purchased), to the extent they would have been dilutive, are included in the denominator of the diluted EPS calculation. The dilutive effect of our convertible preferred stock is computed using the if-converted method, which assumes conversion at the beginning of the year. However, when a net loss exists, no potential common stock equivalents are included in the computation of the diluted per-share amount because the computation would result in an anti-dilutive per-share amount.
iPotentially dilutive securities outstanding as of June 30, 2021 and 2020, which were excluded from the computation of basic and diluted net loss per share for the years then ended, are as follows:
| | | | |
| | June 30, | ||
( in thousands) | | 2021 |
| 2020 |
Preferred stock (1) |
| i — |
| i 287 |
Options |
| i 274 |
| i 749 |
Warrants |
| i 45 |
| i 283 |
Restricted stock units |
| i 1,125 |
| i 752 |
Total |
| i 1,444 |
| i 2,071 |
| (1) | Represents number of shares of common stock that are issuable upon conversion of outstanding shares of Series A Convertible Preferred Stock. |
10
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
iThe following table summarizes the stock option, warrants, and RSUs activity for the six months ended June 30, 2021:
| | | | | | |
| | Options |
| Warrants |
| RSUs |
Outstanding at December 31, 2020 |
| i 516,911 | | i 81,053 |
| i 958,378 |
Granted |
| i 39,186 | | — |
| i 451,435 |
Exercised/Settled |
| ( i 220,708) | | ( i 29,280) |
| ( i 169,939) |
Forfeited/Expired |
| ( i 61,498) | | ( i 7,200) |
| ( i 114,594) |
Outstanding at June 30, 2021 |
| i 273,891 | | i 44,573 |
| i 1,125,280 |
Vested at June 30, 2021 | | i 112,313 | | i 44,573 | | i 303,905 |
Unvested at June 30, 2021 | | i 161,578 | | — | | i 821,375 |
iNOTE 3 — CAPITAL RAISE AND LIQUIDITY
On February 11, 2021, we entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (“Agent”) under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock to or through the Agent as its sales agent, having an aggregate offering price of up to $ i 30,000,000. In the six months ended June 30, 2021, we sold a total of i 471,970 shares of common stock under this Sales Agreement for total proceeds of approximately $ i 16.5 million, net of estimated transaction costs.
/ iNOTE 4 — LEASE LIABILITIES AND RIGHT OF USE ASSETS
We determine whether an arrangement is a lease at inception. Right-of-use assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease.
Finance Leases
The Company has finance leases to purchase computer equipment. The amortization expense of the leased equipment is included in depreciation expense. As of June 30, 2021 and December 31, 2020, the Company’s outstanding finance lease obligations totaled $ i 140,000 and $ i 61,000, respectively. The effective interest rate of the finance leases is estimated at i 6.0% based on the implicit rate in the lease agreements.
iThe following summarizes the assets acquired under finance leases, included in property and equipment:
| | | | | | |
|
| June 30, |
| December 31, | ||
(in thousands) | | 2021 | | 2020 | ||
Computer equipment | | $ | i 282 | | $ | i 177 |
Less: accumulated depreciation | |
| ( i 146) | |
| ( i 116) |
Assets acquired under finance leases, net | | $ | i 136 | | $ | i 61 |
/11
NOTE 4 — LEASE LIABILITIES AND RIGHT OF USE ASSETS (continued)
Operating Leases
Operating lease right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Since our lease arrangements do not provide an implicit rate, we use our estimated incremental borrowing rate for the expected remaining lease term at commencement date in determining the present value of future lease payments. Operating lease expense is recognized on a straight-line basis over the lease term.
The Company has operating leases for office space in Tucson, Arizona and Marietta, Georgia.
In addition, the Company entered into membership agreements to occupy shared office space in New York, Austin, Texas, and Portland, Oregon. The membership agreements do not qualify as a lease under ASC 842 as the owner has substantive substitution rights, therefore the Company expenses membership fees as they are incurred. See Note 8 - Commitments and Contingencies for further details on our shared office arrangements.
The Company made operating lease payments in the amount of $ i 130,000 during the six months ended June 30, 2021.
iThe following summarizes the total lease liabilities and remaining future minimum lease payments at June 30, 2021 (in thousands):
| | | | | | | | | |
Year ending December 31, |
| Finance Leases |
| Operating Leases |
| Total | |||
2021 (6 months remaining) | | $ | i 42 | | $ | i 132 | | $ | i 174 |
2022 | |
| i 61 | |
| i 257 | |
| i 318 |
2023 | |
| i 40 | |
| i 118 | |
| i 158 |
2024 | |
| i 7 | |
| i 81 | |
| i 88 |
Total minimum lease payments | |
| i 150 | |
| i 588 | |
| i 738 |
Less: present value discount | |
| ( i 10) | |
| ( i 44) | |
| ( i 54) |
Total lease liabilities | |
| i 140 | | | i 544 | | | i 684 |
Current portion of lease liabilities | |
| i 69 | | | i 240 | | | i 309 |
Long term portion of lease liabilities | | $ | i 71 | | $ | i 304 | | $ | i 375 |
iThe following summarizes expenses associated with our finance and operating leases for the six months ended June 30, 2021 (in thousands):
| | | |
Finance lease expenses: |
| | |
Depreciation expense | | $ | i 42 |
Interest on lease liabilities | |
| i 4 |
Total Finance lease expense | |
| i 46 |
Operating lease expense | |
| i 128 |
Short-term lease and related expenses | |
| i 104 |
Total lease expenses | | $ | i 278 |
12
NOTE 4 — LEASE LIABILITIES AND RIGHT OF USE ASSETS (continued)
i
The following table provides information about the remaining lease terms and discount rates applied as of June 30, 2021:
| | |
Weighted average remaining lease term (years) |
|
|
Operating Leases |
| i 2.52 |
Finance Leases |
| i 2.26 |
Weighted average discount rate (%) |
| |
Operating Leases |
| i 6.00 |
Finance Leases |
| i 6.00 |
iNOTE 5 — DEBT
Term loan
On April 15, 2020, the Company entered into a loan agreement in the amount of $ i 1,302,000 with Liberty Capital Bank (“Lender”) pursuant to the Paycheck Protection Program (“PPP Loan”) of the CARES Act, which is administered by the Small Business Administration (“SBA”). The loan had a maturity of i two years and bore an interest rate of i 1.0% per annum. In the second quarter of 2021, the SBA approved the Company’s PPP Loan forgiveness application and paid to the Lender the full amount of the PPP Loan and accrued interest thereon on the Company’s behalf, releasing AudioEye from any obligations. In connection with the full forgiveness of the outstanding principal and interest on our PPP Loan, we recorded a $ i 1,316,000 gain on loan forgiveness in the six months ended June 30, 2021.
/
iNOTE 6 — SERIES A CONVERTIBLE PREFERRED STOCK
In the second quarter of 2021, all i 90,000 shares of the outstanding Series A Convertible Preferred Stock (the “Preferred Stock”) were converted to common stock prior to their authorized redemption date of May 25, 2021, as previously announced by the Company. In connection with the Preferred Stock conversion, we issued i 279,137 shares of our common stock. As of June 30, 2021, there were i no shares of Preferred Stock outstanding.
/
iNOTE 7 — RELATED PARTY TRANSACTIONS
In the second quarter of 2021, we terminated the lease with a company controlled by our Executive Chairman and closed our Scottsdale, AZ office. For the three- and six-month period ended June 30, 2021, rent payments for this office space totaled $ i 7,000 and $ i 24,000, respectively.
/ iNOTE 8 — COMMITMENTS AND CONTINGENCIES
Membership agreement to occupy shared office space
The Company occupies shared office space in New York, NY, Portland, OR, and Austin, TX under membership agreements which ends in July 2021, August 2021 and May 2022, respectively. Fees due under these membership agreements are based on the number of contracted seats and the use of optional office services. As of June 30, 2021, minimum fees due under these shared office arrangements totaled $ i 72,000.
/13
NOTE 8 — COMMITMENTS AND CONTINGENCIES (continued)
Litigation
We may become involved in various routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.
14
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, should be read in conjunction with our financial statements and related notes in Part I, Item 1 of this report.
As used in this quarterly report, the terms “we,” “us,” “our” and similar references refer to AudioEye, Inc., unless otherwise indicated.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In some cases, you may be able to identify forward-looking statements by terms such as “may,” “should,” “will,” “forecasts,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential” or “continue,” the negative of these terms and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements, and are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions and speak only as of the date on which they are made.
Because these forward-looking statements involve known and unknown risks and uncertainties, there are important factors that could cause actual results, events or developments to differ materially from those expressed or implied by these forward-looking statements, including our plans, objectives, expectations and intentions and other factors discussed in “Part I, Item 1A. Risk Factors” contained in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. Risk factors that could cause actual results to differ from those contained in the forward-looking statements include but are not limited to risks related to:
| ● | the adverse impact of the COVID-19 pandemic on our business and results of operations; |
| ● | the uncertain market acceptance of our existing and future products; |
| ● | our need for, and the availability of, additional capital in the future to fund our operations and the development of new products; |
| ● | the success, timing and financial consequences of new strategic relationships or licensing agreements we may enter into; |
| ● | rapid changes in Internet-based applications that may affect the utility and commercial viability of our products; |
| ● | the timing and magnitude of expenditures we may incur in connection with our ongoing product development activities; |
| ● | the level of competition from our existing competitors and from new competitors in our marketplace; and |
| ● | the regulatory environment for our products and services. |
Readers of this report are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. This cautionary note is applicable to all forward-looking statements contained in this report.
15
Background
AudioEye, Inc. (“AudioEye” or the “Company”) was formed as a Delaware corporation on May 20, 2005. On August 1, 2018, the Company amended its Certificate of Incorporation to implement a reverse stock split in the ratio of 1 share for every 25 shares of common stock and to reduce the number of authorized shares of common stock from 250,000,000 to 50,000,000. As a result, 186,994,384 shares of the Company’s common stock were exchanged for 7,479,775 shares of the Company’s common stock.
Overview
AudioEye is an industry-leading software solution provider delivering website accessibility compliance at all price points to businesses of all sizes. Our solutions advance accessibility with patented technology that reduces barriers, expands access for individuals with disabilities, and enhances the user experience for a broader audience. We believe that, when implemented, our solution offers businesses and organizations the opportunity to reach more customers, improve brand image, build additional brand loyalty, and, most importantly, provide an accessible and usable web experience to the expansive and ever-growing global population of individuals with disabilities.
AudioEye primarily generates revenue through the sale of subscriptions for our software-as-a-service (“SaaS”) accessibility solutions. Our solutions are backed by AudioEye’s machine-learning/AI-driven technology that finds and fixes common accessibility errors. Our core and supplemental solutions are designed to help websites and applications achieve and sustain substantial conformance with AudioEye’s interpretation of the Web Content Accessibility Guidelines (“WCAG”) which are web accessibility standards published by the Web Accessibility Initiative of the World Wide Web Consortium, the main international standards organization for the internet. Our solutions help mitigate a customer’s risk of costly digital accessibility-related legal action. AudioEye customers may purchase solutions directly through the AudioEye Marketplace, through a platform partner or an agency, such as Duda, that integrates our solutions into their marketplace, through a vertical Content Management System (“CMS”) partner, through an authorized reseller, or by working directly with the AudioEye sales team. Our offerings serve businesses and organizations of all sizes and at all price points.
AudioEye stands out among its competitors because it delivers machine-learning/artificial intelligence (“AI”)-driven accessibility without fundamental changes to the website architecture. As another differentiator, we offer transparency. Our offerings provide automated remediations and a transparent compliance score with additional manually driven enhancements. AudioEye pairs its patented technology solutions with certified accessibility experts, which allows our customers to achieve a higher level of compliance than competitors relying solely on automation. Our solution is trusted by some of the largest and most influential companies in the world, including ADP, Tommy Hilfiger, 360 Media, Samsung, Darden, Landry’s and more. Government agencies, from the federal level down to the local level, have also integrated our software in their digital platforms, including the Federal Communications Commission and the Social Security Administration.
The AudioEye Solutions
At its core, AudioEye’s provides an always-on testing, remediation, and monitoring solution that continually improves conformance with WCAG. This in turn helps businesses and organizations comply with WCAG standards as well as applicable U.S. and foreign accessibility laws. Our technology is capable of immediately identifying and fixing most of the common accessibility errors and addresses a wide range of disabilities including dyslexia, color blindness, epilepsy and more. AudioEye also offers additional solutions to provide for enhanced compliance and accessibility, including periodic manual auditing, manual remediations and legal support services. Our solutions may be purchased through a subscription service on a month-to-month basis or with one or multi-year terms. We also offer PDF remediation services and Native Mobile App audit reports to help our customers with their digital accessibility needs.
Intellectual Property
Our intellectual property is primarily comprised of copyrights, trademarks, trade secrets, issued patents and pending patent applications. We have a patent portfolio comprised of nineteen (19) issued patents in the United States. We also have six (6) pending patent applications and two (2) international patent applications. The commercial value of these patents is unknown.
We plan to continue to invest in research and development and expand our portfolio of proprietary intellectual property.
Our Annual Report filed on Form 10-K for the year ended December 31, 2020 as filed with the SEC on March 11, 2021 provides additional information about our business and operations.
16
Results of Operations
Our unaudited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP” or “GAAP”). The discussion of the results of our operations compares the three and six months ended June 30, 2021 with the three and six months ended June 30, 2020.
Our results of operations in these interim periods are not necessarily indicative of the results which may be expected for any subsequent period. Due to rounding, numbers presented throughout this document may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
| | | | | | | | | | | | |
| | Three months ended | | |
| |||||||
| | June 30, | | Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % |
| |||
Revenue | | $ | 6,021 | | $ | 5,283 | | $ | 738 | | 14 | % |
Cost of revenue | |
| (1,512) | |
| (1,607) | |
| 95 | | (6) | % |
Gross profit | |
| 4,509 | |
| 3,676 | |
| 833 | | 23 | % |
Operating expenses: | |
| | |
| | |
| | | | |
Selling and marketing | |
| 3,380 | |
| 1,705 | |
| 1,675 | | 98 | % |
Research and development | |
| 1,307 | |
| 265 | |
| 1,042 | | 393 | % |
General and administrative | |
| 2,917 | |
| 2,556 | |
| 361 | | 14 | % |
Total operating expenses | |
| 7,604 | |
| 4,526 | |
| 3,078 | | 68 | % |
Operating loss | |
| (3,095) | |
| (850) | |
| (2,245) | | 264 | % |
Other income (expense): | |
| | |
| | |
| | | | |
Change in fair value of warrant liability | |
| — | |
| (501) | |
| 501 | | (100) | % |
Gain on loan forgiveness | | | 1,316 | | | — | | | 1,316 | | 100 | % |
Interest expense | |
| (5) | |
| (56) | |
| 51 | | (91) | % |
Total other income (expense) | |
| 1,311 | |
| (557) | |
| 1,868 | | 335 | % |
Net loss | | $ | (1,784) | | $ | (1,407) | | $ | (377) | | 27 | % |
| | | | | | | | | | | | |
|
| Six months ended | | | | | |
| ||||
| | June 30, | | Change |
| |||||||
(in thousands) | | | 2021 |
| | 2020 |
| | $ |
| % |
|
Revenue | | $ | 11,809 | | $ | 9,544 | | $ | 2,265 | | 24 | % |
Cost of revenue | |
| (2,865) | |
| (2,927) | |
| 62 | | (2) | % |
Gross profit | |
| 8,944 | |
| 6,617 | |
| 2,327 | | 35 | % |
Operating expenses: | |
|
| |
|
| |
|
| |
| |
Selling and marketing | |
| 6,134 | |
| 3,523 | |
| 2,611 | | 74 | % |
Research and development | |
| 2,339 | |
| 598 | |
| 1,741 | | 291 | % |
General and administrative | |
| 6,327 | |
| 4,988 | |
| 1,339 | | 27 | % |
Total operating expenses | |
| 14,800 | |
| 9,109 | |
| 5,691 | | 62 | % |
Operating loss | |
| (5,856) | |
| (2,492) | |
| (3,364) | | 135 | % |
Other income (expense): | |
|
| |
|
| |
|
| |
| |
Change in fair value of warrant liability | |
| — | |
| (473) | |
| 473 | | (100) | % |
Gain on loan forgiveness | |
| 1,316 | |
| — | |
| 1,316 | | 100 | % |
Interest expense | |
| (9) | |
| (106) | |
| 97 | | (92) | % |
Total other income (expense) | |
| 1,307 | |
| (579) | |
| 1,886 | | 326 | % |
Net loss | | $ | (4,549) | | $ | (3,071) | | $ | (1,478) | | 48 | % |
17
Revenue
The following tables present our revenues disaggregated by sales channel:
| | | | | | | | | | | | |
|
| Three months ended June 30, |
| Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % | | |||
Partner and Marketplace | | $ | 3,374 | | $ | 2,358 | | $ | 1,016 | | 43 | % |
Enterprise | |
| 2,647 | |
| 2,925 | | | (278) | | (10) | % |
Total revenues | | $ | 6,021 | | $ | 5,283 | | $ | 738 | | 14 | % |
| | | | | | | | | | | | |
|
| Six months ended | | |
| |||||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 |
| 2020 |
| $ |
| % |
| |||
Partner and Marketplace | | $ | 6,552 | | $ | 4,232 | | $ | 2,320 | | 55 | % |
Enterprise | |
| 5,257 | |
| 5,312 | |
| (55) | | (1) | % |
Total revenues | | $ | 11,809 | | $ | 9,544 | | $ | 2,265 | | 24 | % |
Partner and Marketplace channel consists of our CMS partners, platform & agency partners, authorized resellers and the Marketplace. This channel serves small & medium sized businesses that are on a partner or reseller’s web-hosting platform or that purchase our solutions from our Marketplace.
Enterprise channel consists of our larger customers and organizations, including those with non-platform custom websites, who generally engage directly with AudioEye sales personnel for custom pricing and solutions. This channel also includes federal, state and local government agencies.
For the three and six months ended June 30, 2021, total revenue increased by 14% and 24%, respectively, over the prior year comparable periods. This increase in total revenues was driven by higher Partner and Marketplace channel revenue as a result of our continued focus on highly transactional industry verticals to achieve higher penetration within our existing partnerships. The decrease in Enterprise channel revenue was primarily due to timing of customer demand for our PDF remediation services, and was partially offset by the increase in recurring revenue sources, which were 11% and 12% higher in the three and six months ended June 30, 2021, respectively, than in the prior year comparable periods.
Cost of Revenue and Gross Profit
| | | | | | | | | | | | |
| | Three months ended June 30, |
| Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % |
| |||
Revenue | | $ | 6,021 | | $ | 5,283 | | $ | 738 | | 14 | % |
Cost of Revenue | |
| (1,512) | |
| (1,607) | |
| 95 | | (6) | % |
Gross profit | | $ | 4,509 | | $ | 3,676 | | $ | 833 | | 23 | % |
| | | | | | | | | | | | |
|
| Six months ended | |
| ||||||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 |
| 2020 |
| $ |
| % |
| |||
Revenue | | $ | 11,809 | | $ | 9,544 | | $ | 2,265 |
| 24 | % |
Cost of Revenue | |
| (2,865) | |
| (2,927) | |
| 62 |
| (2) | % |
Gross profit | | $ | 8,944 | | $ | 6,617 | | $ | 2,327 |
| 35 | % |
Cost of revenue consists primarily of compensation and related benefits costs for our customer experience team, as well as a portion of our technology operations team that supports the delivery of our services, fees paid to our managed hosting and other third-party service providers, amortization of capitalized software development costs and patent costs, and allocated overhead costs.
For the three and six months ended June 30, 2021, cost of revenue decreased by 6% and 2%, respectively, from the prior year comparable periods. This slight decrease in cost of revenue is primarily due to a reduction in delivery support costs from continuous efficiencies, partially offset by an increase is cost of hosting fees and amortization of capitalized software development costs.
18
For the three and six months ended June 30, 2021, gross profit increased by 23% and 35%, respectively, over the prior year comparable periods. The increase in gross profit was a result of increased revenue and continued improvement in technology driven efficiencies as we scale, offset in part by higher costs to support the revenue growth.
Selling and Marketing Expenses
| | | | | | | | | | | | |
|
| Three months ended June 30, |
| Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % |
| |||
Selling and marketing | | $ | 3,380 | | $ | 1,705 | | $ | 1,675 | | 98 | % |
| | | | | | | | | | | | |
|
| Six months ended | | | | | |
| ||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 |
| 2020 |
| $ |
| % |
| |||
Selling and marketing | | $ | 6,134 | | $ | 3,523 | | $ | 2,611 | | 74 | % |
Selling and marketing expenses consist primarily of compensation and benefits related to our sales and marketing staff, as well as third-party advertising and marketing expenses.
For the three and six months ended June 30, 2021, selling and marketing expenses increased by 98% and 74%, respectively, over the prior year comparable periods. The increase in selling and marketing expenses resulted primarily from an increase in personnel costs, driven by focused talent acquisition, and higher digital and third-party marketing agency expenses as we continue to expand our business.
Research and Development Expenses
| | | | | | | | | | | | |
|
| Three months ended June 30, |
| Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % |
| |||
Research and development expense | | $ | 1,307 | | $ | 265 | | $ | 1,042 | | 393 | % |
Plus: Capitalized research and development cost | |
| 597 | |
| 246 | |
| 351 | | 143 | % |
Total research and development cost | | $ | 1,904 | | $ | 511 | | $ | 1,393 | | 273 | % |
| | | | | | | | | | | | |
|
| Six months ended | | |
| |||||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 |
| 2020 |
| $ |
| % |
| |||
Research and development expense | | $ | 2,339 | | $ | 598 | | $ | 1,741 | | 291 | % |
Plus: Capitalized research and development cost | |
| 843 | |
| 370 | |
| 473 | | 128 | % |
Total research and development cost | | $ | 3,182 | | $ | 968 | | $ | 2,214 | | 229 | % |
Research and development (“R&D”) expenses consist primarily of compensation and related benefits, independent contractor costs, and an allocated portion of general overhead costs, including occupancy costs related to our employees involved in research and development activities. Total research and development cost includes the amount of research and development expense reported within operating expenses as well as development cost that was capitalized during the fiscal period.
19
For the three and six months ended June 30, 2021, research and development expenses increased by 393% and 291%, respectively, over the prior year comparable periods. This increase was driven by higher investment in non-capitalizable R&D efforts related to our new product and platform development as we test and learn new capabilities and continuously enhance our offerings. For the three and six months ended June 30, 2021, capitalized research and development cost increased 143% and 128%, respectively, over the prior year comparable periods, driven by increased investment in our platforms and products as we continue to improve our technology and product delivery to help our customers and gain efficiencies as we scale. For the three and six months ended June 30, 2021, total research and development cost, which includes both R&D expenses and capitalized R&D costs, increased by 273% and 229%, respectively, over the prior year comparable periods.
General and Administrative Expenses
| | | | | | | | | | | | |
|
| Three months ended June 30, |
| Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % |
| |||
General and administrative | | $ | 2,917 | | $ | 2,556 | | $ | 361 | | 14 | % |
| | | | | | | | | | | | |
|
| Six months ended | | |
| |||||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 |
| 2020 |
| $ |
| % |
| |||
General and administrative | | $ | 6,327 | | $ | 4,988 | | $ | 1,339 | | 27 | % |
General and administrative expenses consist primarily of compensation and benefits related to our executives, directors, corporate support functions and administrative staff, general corporate expenses including legal fees, and occupancy costs.
For the three and six months ended June 30, 2021, general and administrative expenses increased by 14% and 27% over the prior year comparable period. The increase in general and administrative expenses was due primarily to higher compensation costs, including stock-based compensation expense, driven by increased headcount to support the Company’s growth, systems infrastructure improvement and legal expenses towards intellectual property litigation pursued by the Company.
Change in fair value of warrant liability
| | | | | | | | | | | | |
|
| Three months ended June 30, |
| Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % |
| |||
Change in fair value of warrant liability | | $ | — |
| $ | (501) | | $ | 501 | | (100) | % |
| | | | | | | | | | | | |
|
| Six months ended |
| |
| |||||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 |
| 2020 | | $ |
| % |
| |||
Change in fair value of warrant liability | | $ | — | | $ | (473) | | $ | 473 | | (100) | % |
Change in fair value of warrant liability consists of fair value adjustments associated with warrants to purchase 146,667 shares of the Company’s common stock, which were issued in consideration for the credit facility extended by Sero Capital in the third quarter of 2019. In the third quarter of 2020, the warrants were fully exercised and the related liability was extinguished.
Gain on loan forgiveness
| | | | | | | | | | | | |
|
| Three and six months ended |
| |
| |||||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 |
| 2020 | | $ |
| % |
| |||
Gain on loan forgiveness | | $ | 1,316 | | $ | — | | $ | 1,316 | | 100 | % |
In the second quarter of 2021, we recorded a $1,316,000 gain on loan forgiveness in connection with the full forgiveness of the outstanding principal and interest on our PPP Loan.
20
Interest Expense
| | | | | | | | | | | | |
|
| Three months ended June 30, |
| Change |
| |||||||
(in thousands) |
| 2021 |
| 2020 |
| $ |
| % |
| |||
Interest expense | | $ | 5 |
| $ | 56 | | $ | (51) | | (91) | % |
| | | | | | | | | | | | |
|
| Six months ended |
| |
| |||||||
| | June 30, | | Change |
| |||||||
(in thousands) | | 2021 | | 2020 | | $ |
| % |
| |||
Interest expense | | $ | 9 | | $ | 106 | | $ | (97) | | (92) | % |
Interest expense in the three and six months ended 2021 consists primarily of interest on our PPP Loan and finance lease liabilities. The higher interest expense for the three and six months ended June 30, 2020 was attributable to the amortization of deferred issuance costs associated with our line of credit, which expired in August 2020.
Key Operating Metrics
We consider monthly recurring revenue (“MRR”) as a key operating metric and a key indicator of our overall business. We also use MRR as (i) one of the primary methods for planning and forecasting overall expectations and for evaluating, on at least a quarterly and annual basis, actual results against such expectations; and (ii) as a performance metric for certain executive stock-based compensation awards.
We define MRR as the sum of (i) for our Enterprise channel, the total of the average monthly recurring fee amount under each active paid contract at the date of determination, plus (ii) for our Partner and Marketplace channel, the recognized monthly fee amount for all paying customers at the date of determination, in each case, assuming no changes to the subscription and without taking into account any usage above the subscription or recurring revenue base, if any, that may be applicable to such subscription. This determination includes both annual and monthly contracts for recurring products. Some of our contracts are cancelable, which may impact future MRR. MRR excludes revenue from our PDF remediation services business and Mobile App report business. As of June 30, 2021, MRR was about $2.0 million, which represents an increase of 25% year-over-year driven by both our Partner and Marketplace channel and Enterprise Channel.
Use of Non-GAAP Financial Measures
From time to time, we review adjusted financial measures that assist us in comparing our operating performance consistently over time, as such measures remove the impact of certain items, as applicable, such as our capital structure (primarily interest charges), items outside the control of the management team (taxes), and expenses that do not relate to our core operations, including transaction-related expenses and other costs that are expected to be non-recurring. In order to provide investors with greater insight, and allow for a more comprehensive understanding of the information used in our financial and operational decision-making, the Company has supplemented the Financial Statements presented on a GAAP basis in this Quarterly Report on Form 10-Q with the following non-GAAP financial measures: Non-GAAP earnings (loss) and Non-GAAP earnings (loss) per diluted share.
These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of Company results as reported under GAAP. The Company compensates for such limitations by relying primarily on our GAAP results and using non-GAAP financial measures only as supplemental data. We also provide a reconciliation of non-GAAP to GAAP measures used. Investors are encouraged to carefully review this reconciliation. In addition, because these non-GAAP measures are not measures of financial performance under GAAP and are susceptible to varying calculations, these measures, as defined by us, may differ from and may not be comparable to similarly titled measures used by other companies.
21
Non-GAAP Earnings (Loss) and Non-GAAP Earnings (Loss) per Diluted Share
We define: (i) Non-GAAP earnings (loss) as net income (loss), less non-cash valuation adjustments to liabilities, plus interest expense, plus stock-based compensation expense, plus loss on impairment of long-lived assets, plus loss on disposal of property and equipment, and less gain on loan forgiveness; and (ii) Non-GAAP earnings (loss) per diluted share as net income (loss) per diluted common share, less non-cash valuation adjustments to liabilities, plus interest expense, plus stock-based compensation expense plus loss on impairment of long-lived assets, plus loss on disposal of property and equipment, and less gain on loan forgiveness, each on a per share basis. Non-GAAP earnings per diluted share would include incremental shares in the share count that are considered anti-dilutive in a GAAP net loss position. However, no incremental shares apply when there is a Non-GAAP loss per diluted share, as is the case for the periods presented in this Quarterly Report on Form 10-Q.
Non-GAAP earnings (loss) and Non-GAAP earnings (loss) per diluted share are used to facilitate a comparison of our operating performance on a consistent basis from period to period and provide for a more complete understanding of factors and trends affecting our business than GAAP measures alone. All of the items adjusted in the Non-GAAP earnings (loss) to net loss and the related per share calculations are either recurring non-cash items, or items that management does not consider in assessing our on-going operating performance. In the case of the non-cash items, such as stock-based compensation expense and valuation adjustments to assets and liabilities, management believes that investors may find it useful to assess our comparative operating performance without these items because the measures without such items are expected to be less susceptible to variances in actual performance resulting from expenses that do not relate to our core operations and are more reflective of other factors that affect operating performance. In the case of items that do not relate to our core operations, management believes that investors may find it useful to assess our operating performance if the measures are presented without these items because their financial impact does not reflect ongoing operating performance.
Non-GAAP earnings (loss) is not a measure of liquidity under GAAP, or otherwise, and is not an alternative to cash flow from continuing operating activities, despite the advantages regarding the use and analysis of these measures as mentioned above. Non-GAAP earnings (loss) and Non-GAAP earnings (loss) per diluted share, as disclosed in this Quarterly Report on Form 10-Q, have limitations as analytical tools, and you should not consider these measures in isolation or as a substitute for analysis of our results as reported under GAAP; nor are these measures intended to be measures of liquidity or free cash flow for our discretionary use.
22
To properly and prudently evaluate our business, we encourage readers to review the GAAP financial statements included elsewhere in this Quarterly Report on Form 10-Q, and not rely on any single financial measure to evaluate our business. The following table sets forth reconciliations of Non-GAAP loss to net loss, the most directly comparable GAAP-based measure, as well as Non-GAAP loss per diluted share to net loss per diluted share, the most directly comparable GAAP-based measure.
| | | | | | | | | | | | |
|
| Three months ended June 30, | | Six months ended June 30, | ||||||||
(in thousands, except per share data) |
| 2021 |
| 2020 | | 2021 |
| 2020 | ||||
Non-GAAP Earnings (Loss) Reconciliation | | |
|
| |
| | | | | | |
Net loss (GAAP) | | $ | (1,784) | | $ | (1,407) | | $ | (4,549) | | $ | (3,071) |
Non-cash valuation adjustments to liabilities | |
| — | |
| 501 | |
| — | |
| 473 |
Interest expense | |
| 5 | |
| 56 | |
| 9 | |
| 106 |
Stock-based compensation expense | |
| 1,763 | |
| 659 | |
| 3,544 | |
| 915 |
Loss on impairment of long-lived assets | |
| — | |
| — | |
| 10 | |
| — |
Loss on disposal of property and equipment | |
| 5 | |
| — | |
| 12 | |
| — |
Gain on loan forgiveness | | | (1,316) | | | — | | | (1,316) | | | — |
Non-GAAP loss | | $ | (1,327) | | $ | (191) | | $ | (2,290) | | $ | (1,577) |
| | | | | | | | | | | | |
Non-GAAP Earnings (Loss) per Diluted Share Reconciliation | |
|
| |
|
| |
| | |
| |
Net loss per common share (GAAP) — diluted | | $ | (0.17) | | $ | (0.16) | | $ | (0.43) | | $ | (0.35) |
Non-cash valuation adjustments to liabilities | |
| — | |
| 0.06 | |
| — | |
| 0.05 |
Interest expense | |
| — | |
| 0.01 | |
| — | |
| 0.01 |
Stock-based compensation expense | |
| 0.16 | |
| 0.07 | |
| 0.33 | |
| 0.10 |
Loss on impairment of long-lived assets | |
| — | |
| — | |
| — | |
| — |
Loss on disposal of property and equipment | |
| — | |
| — | |
| — | |
| — |
Gain on loan forgiveness | | | (0.12) | | | — | | | (0.12) | | | — |
Non-GAAP loss per diluted share (1) | | $ | (0.13) | | $ | (0.02) | | $ | (0.22) | | $ | (0.19) |
Diluted weighted average shares (2) | |
| 10,992 | |
| 8,937 | |
| 10,726 | |
| 8,907 |
(1) | Non-GAAP earnings per adjusted diluted share for our common stock is computed using the more dilutive of the two-class method or the if-converted method. |
(2) | The number of diluted weighted average shares used for this calculation is the same as the weighted average common shares outstanding share count when the Company reports a GAAP and non-GAAP net loss. |
Liquidity and Capital Resources
Working Capital
As of June 30, 2021, we had $24,751,000 in cash and working capital of $19,652,000. The increase in working capital in the six months ended June 30, 2021 was primarily a result of capital raised under the previously announced At The Market offering (“ATM offering”) initiated in the first quarter of 2021. In the six months ended June 30, 2021, the Company issued 471,970 shares of its common stock under the ATM offering and raised $16,534,000, net of transaction expenses.
While the Company has been successful in raising capital, there is no assurance that it will be successful at raising additional capital in the future. Additionally, if the Company’s plans are not achieved and/or if significant unanticipated events occur, the Company may have to further modify its business plan, which may require us to raise additional capital.
| | | | | | |
(in thousands) |
|
| ||||
Current assets | | $ | 29,108 | | $ | 14,631 |
Current liabilities | |
| (9,456) | |
| (9,015) |
Working capital | | $ | 19,652 | | $ | 5,616 |
23
Cash Flows
| | | | | | |
|
| Six months ended June 30, | ||||
(in thousands) |
| 2021 |
| 2020 | ||
Net cash provided by (used in) operating activities | | $ | 67 | | $ | (791) |
Net cash used in investing activities | |
| (893) | |
| (370) |
Net cash provided by financing activities | |
| 16,482 | |
| 1,319 |
Net increase in cash | | $ | 15,656 | | $ | 158 |
For the six months ended June 30, 2021, in relation to the prior year comparable period, cash provided by operating activities increased primarily due to an increase in our paying customer base leading to our revenue growth. The effect of higher collections from this expanded customer base was partially offset by the increased personnel and sales and marketing costs, primarily driven by the increase in headcount and related expenses and higher digital, consulting and third-party costs to support the Company’s growth.
For the six months ended June 30, 2021, in relation to the prior year comparable period, cash used in investing activities increased primarily due to investment in new technologies for enhancements to our legacy solutions, product development, as well as patents costs to protect our intellectual property and solidify our portfolio.
For the six months ended June 30, 2021, in relation to the prior year comparable period, cash provided by financing activities increased primarily due to capital raised under the ATM Offering initiated in the first quarter of 2021. In the six months ended June 30, 2021, the Company issued 471,970 shares of its common stock under the ATM offering and raised $16,534,000, net of transaction expenses. We intend to use the proceeds from this offering for working capital and general corporate purposes, including the implementation of our business plan and growth of current operations.
Critical Accounting Policies
The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with U.S. GAAP. Preparing financial statements requires our management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by our management’s application of accounting policies.
Our critical accounting policies, as described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, relate to revenue recognition, allowance for doubtful accounts, capitalized software development costs, and stock-based compensation. There have been no material changes to our critical accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not applicable.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures that are designed to ensure that there is reasonable assurance that the information required to be disclosed in the Company’s reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure based on the definition of “disclosure controls and procedures” in Exchange Act Rules 13a-15(e) and 15d-15(e). In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, projections of any evaluation of effectiveness of our disclosure
24
controls and procedures to future periods are subject to the risk that controls or procedures may become inadequate because of changes in conditions, or that the degree of compliance with the controls or procedures may deteriorate.
As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of the Company’s senior management, including the Interim Chief Executive Officer (Principal Executive Officer) and Executive Chairman (Principal Financial Officer), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures to provide reasonable assurance of achieving the desired objectives of the disclosure controls and procedures. In light of the material weaknesses noted in our Annual Report on Form 10-K for our fiscal year ended December 31, 2020, our Principal Executive Officer and Principal Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective.
Changes in Internal Controls over Financial Reporting
There were no material changes in our internal control over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
25
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
Currently, there are no pending material legal proceedings to which the Company is a party to or to which any of its property is subject.
Item 1A. Risk Factors
You should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 (“2020 Form 10-K”), which could materially affect our business, financial condition and results of operations. The risks described in our 2020 Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or results of operations.
Item 2. Issuer Purchases of Equity Securities
The following table sets forth information with respect to our repurchases of common stock during the three months ended June 30, 2021:
| | | | | | | | | |
|
| |
| | |
| Total Number of |
| Maximum Number |
| | | | | | | Shares Purchased | | of Shares that May |
| | Total Number of | | | | | as Part of Publicly | | Yet Be Purchased |
| | Shares Purchased | | Average Price | | Announced Plans or | | under the Plans or | |
|
| (1) |
| Paid per Share |
| Programs |
| Programs | |
April 1 - April 30 |
| — | | $ | — |
| — |
| — |
May 1 - May 31 |
| 2,332 | |
| 16.74 |
| — |
| — |
June 1 - June 30 |
| 428 | |
| 16.79 |
| — |
| — |
Total |
| 2,760 | | $ | 16.75 |
| — |
| — |
(1) | Amount represents shares surrendered by employees to satisfy tax withholding obligations resulting from restricted stock units settled during the three months ended June 30, 2021. |
26
Item 6. Exhibits
| | |
Exhibit |
| Description |
3.1 | | Certificate of Incorporation of AudioEye, Inc., dated as of May 20, 2005 (1) |
| | |
3.2 | | |
| | |
3.3 | | |
| | |
3.4 | | |
| | |
3.5 | | |
| | |
3.6 | | Certificate of Designations - Series A Convertible Preferred Stock (5) |
| | |
3.7 | | |
| | |
3.8 | | |
| | |
10.1* | | |
| | |
10.2 | | |
| | |
10.3 | | Executive Employment Agreement, dated June 10, 2021, between the Company and Kelly Georgevich (9) |
| | |
31.1* | | |
| | |
32.1* | | |
| | |
101.INS* | | XBRL Instance Document |
| | |
101.SCH* | | XBRL Taxonomy Extension Schema Document |
| | |
101.CAL* | | XBRL Taxonomy Extension Calculation Linkbase Document |
| | |
101.DEF* | | XBRL Taxonomy Extension Definition Linkbase Document |
| | |
101.LAB* | | XBRL Taxonomy Extension Label Linkbase Document |
| | |
101.PRE* | | XBRL Taxonomy Extension Presentation Linkbase Document |
| | |
104* | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS) |
* |
27
(1) | Incorporated by reference to Form S-1, filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 21, 2011 (File No. 333-177463). |
(2) | Incorporated by reference to Form S-1/A, filed with the SEC on October 1, 2012 (File No. 333-177463). |
(3) | Incorporated by reference to Form 10-K, filed with the SEC on March 31, 2014. |
(4) | Incorporated by reference to Form 8-K, filed with the SEC on August 7, 2018. |
(5) | Incorporated by reference to Form 10-K, filed with the SEC on March 30, 2020. |
(6) | Incorporated by reference to Form 8-K, filed with the SEC on June 25, 2021. |
(7) | Incorporated by reference to Form 8-K/A, filed with the SEC on September 24, 2020. |
(8) | Incorporated by reference to Form 8-K, filed with the SEC on June 11, 2021. |
(9) | Incorporated by reference to Form 8-K, filed with the SEC on June 23, 2021. |
28
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | |
| | | AUDIOEYE, INC. | ||
| | | | | |
Date: |
| By: | /s/ David Moradi | ||
| | | | David Moradi | |
| | | | Principal Executive Officer | |
| | | | | |
Date: | | By: | /s/ Dr. Carr Bettis | ||
| | | | Dr. Carr Bettis | |
| | | | Principal Financial Officer | |
29
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/11/21 | 8-K | ||
| 8/6/21 | ||||
| For Period end: | 6/30/21 | 4 | ||
| 6/25/21 | 4, 8-K | |||
| 6/23/21 | 3, 4, 8-K | |||
| 6/11/21 | 8-K | |||
| 5/25/21 | 4, 8-K | |||
| 3/31/21 | 10-Q | |||
| 3/11/21 | 10-K, 4, 8-K | |||
| 2/11/21 | 8-K, EFFECT | |||
| 12/31/20 | 10-K | |||
| 9/24/20 | 4, 8-K/A, SC 13G | |||
| 6/30/20 | 10-Q | |||
| 4/15/20 | 8-K, EFFECT | |||
| 3/31/20 | 10-Q | |||
| 3/30/20 | 10-K, 3 | |||
| 12/31/19 | 10-K | |||
| 8/7/18 | 8-K | |||
| 8/1/18 | 8-K | |||
| 3/31/14 | 10-K, 10-Q, 10-Q/A | |||
| 10/1/12 | CORRESP, S-1/A | |||
| 10/21/11 | S-1 | |||
| 5/20/05 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/07/24 Audioeye Inc. 10-K 12/31/23 74:7.7M Toppan Merrill/FA2 3/09/23 Audioeye Inc. 10-K 12/31/22 75:7.5M Toppan Merrill/FA2 3/11/22 Audioeye Inc. 10-K 12/31/21 72:6.8M Toppan Merrill/FA2 |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/25/21 Audioeye Inc. 8-K:5,9 6/23/21 3:125K Toppan Merrill/FA 6/23/21 Audioeye Inc. 8-K:5,7,9 6/21/21 3:137K Toppan Merrill/FA 6/11/21 Audioeye Inc. 8-K:5,9 6/10/21 2:61K Toppan Merrill/FA 9/24/20 Audioeye Inc. 8-K/A:9 8/13/20 2:95K Toppan Merrill/FA 3/30/20 Audioeye Inc. 10-K 12/31/19 80:7.3M Toppan Merrill/FA 8/07/18 Audioeye Inc. 8-K:1,3,5,7 8/01/18 6:402K Toppan Merrill/FA 3/31/14 Audioeye Inc. 10-K 12/31/13 70:8.4M Toppan Merrill/FA 10/01/12 Audioeye Inc. S-1/A 6:1.9M Quality EDGAR So… LLC/FA 10/21/11 Audioeye Inc. S-1¶ 11:1.9M Gruenbaum Jerry |